DK0393502T3 - Opløselige interferon-gamma-receptorer og fremgangsmåder til fremstilling heraf - Google Patents

Opløselige interferon-gamma-receptorer og fremgangsmåder til fremstilling heraf

Info

Publication number
DK0393502T3
DK0393502T3 DK90106992.2T DK90106992T DK0393502T3 DK 0393502 T3 DK0393502 T3 DK 0393502T3 DK 90106992 T DK90106992 T DK 90106992T DK 0393502 T3 DK0393502 T3 DK 0393502T3
Authority
DK
Denmark
Prior art keywords
methods
gamma receptors
preparation
soluble interferon
soluble
Prior art date
Application number
DK90106992.2T
Other languages
English (en)
Inventor
Michael Fountoulakis
Gianni Garotta
Dietrich Stueber
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK0393502T3 publication Critical patent/DK0393502T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK90106992.2T 1989-04-19 1990-04-11 Opløselige interferon-gamma-receptorer og fremgangsmåder til fremstilling heraf DK0393502T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP89810295 1989-04-19

Publications (1)

Publication Number Publication Date
DK0393502T3 true DK0393502T3 (da) 1996-03-04

Family

ID=8203144

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90106992.2T DK0393502T3 (da) 1989-04-19 1990-04-11 Opløselige interferon-gamma-receptorer og fremgangsmåder til fremstilling heraf

Country Status (11)

Country Link
EP (1) EP0393502B1 (da)
JP (1) JPH02303490A (da)
AT (1) ATE132191T1 (da)
AU (1) AU625866B2 (da)
CA (1) CA2014752A1 (da)
DE (1) DE69024398T2 (da)
DK (1) DK0393502T3 (da)
IE (1) IE901373L (da)
IL (1) IL94081A (da)
NZ (1) NZ233308A (da)
ZA (1) ZA902843B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL88378A (en) * 1988-11-14 2000-11-21 Yeda Res & Dev Human interferon-gamma binding proteins their manufacture and pharmaceutical compositions comprising them
IL91562A0 (en) * 1989-09-07 1990-04-29 Yeda Res & Dev Interferon-gamma receptor fragment and its production
DE69104356T2 (de) * 1990-04-24 1995-03-02 Schering Corp Lösliche verkürzte interferon-gamma rezeptoren.
WO1994012531A1 (en) * 1992-11-20 1994-06-09 Schering Corporation Antagonists of human gamma interferon
DK0695189T3 (da) 1992-12-29 1999-08-09 Genentech Inc Behandling af inflammatorisk tarmsygdom med IFN-gammainhibitorer
CA2114168A1 (en) * 1993-03-05 1994-09-06 Zlatko Dembic Chimeric human interferon-gamma-receptor/immunoglobulin polypeptides
IL107378A (en) * 1993-10-24 2005-05-17 Yeda Res & Dev SOLUBLE INTERFERON alpha-RECEPTOR, ITS PREPARATION AND USE
US20020025316A1 (en) 1995-08-18 2002-02-28 Ferguson Mark Williams James Pharmaceutical composition containing inhibitors of interferon-gamma
GB2304342A (en) * 1995-08-18 1997-03-19 Univ Manchester Pharmaceutical comprising either an inhibitor or a stimulator of interferon gamma
DE69631540T2 (de) * 1995-11-23 2005-01-27 Cancer Research Technology Ltd. Materialien und methoden mit bezug zur identifizierung und sequenzierung des krebs-suszeptilitaetsgens brca2 und dessen anwendungen
US6606103B1 (en) 1999-11-30 2003-08-12 Uhc Llc Infinite resolution scheme for graphical user interface object
US7020843B2 (en) 1999-11-30 2006-03-28 Uhc Llc Method and system for implementing a browser object container
CU23229A1 (es) * 2002-05-10 2007-09-26 Ct Ingenieria Genetica Biotech ANTAGONISTA QUIMéRICO ANTH1
US7608430B2 (en) 2005-07-08 2009-10-27 Regeneron Pharmaceuticals, Inc. Interferon-γ antagonists and therapeutic uses thereof
GB0624071D0 (en) * 2006-12-01 2007-01-10 Bioline Res Ltd Purification methods and materials
AU2024334289A1 (en) 2023-08-25 2026-04-09 Proteologix Us Inc. Anti-il-13 multispecific antibody constructs and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL78444A (en) * 1986-04-08 1992-05-25 Yeda Res & Dev Human gamma interferon-specific receptor protein,antibody against said protein,and compositions containing said protein and antibody

Also Published As

Publication number Publication date
IL94081A0 (en) 1991-01-31
DE69024398D1 (de) 1996-02-08
NZ233308A (en) 1992-11-25
AU5309390A (en) 1990-11-08
JPH02303490A (ja) 1990-12-17
AU625866B2 (en) 1992-07-16
EP0393502A1 (en) 1990-10-24
CA2014752A1 (en) 1990-10-19
EP0393502B1 (en) 1995-12-27
IE901373L (en) 1990-10-19
IL94081A (en) 1996-09-12
ZA902843B (en) 1990-12-28
ATE132191T1 (de) 1996-01-15
DE69024398T2 (de) 1996-06-13

Similar Documents

Publication Publication Date Title
DK0393502T3 (da) Opløselige interferon-gamma-receptorer og fremgangsmåder til fremstilling heraf
IS1584B (is) Aðferð við að framleiða lyfjablöndu er stýrir losun díhýdrópýridíns og beta-adrenoviðtaka antagónista
DE3751306D1 (de) Re-Assoziationsverfahren zur Kodeoptimierung.
DK118887D0 (da) Fremgangsmaade til indvinding af mikrobielt produceret, rekombinant, oploeseligt ricintoxin-a-kaede
DE3788788D1 (de) Zange zum Spreizen von Wirbelsäulenkörpern.
NO884135D0 (no) Vannopploeselig cellulosederivat, fremgangsmaate for dets fremstilling og anvendelse derav.
DK94783D0 (da) Fremgangsmade til fremstilling af kvaternaere 6,11-dihydro-dibenzo-(b,e)-thiepin-11-n-alkyl-norscopinethere og mellemprodukter herfor
DK0400583T3 (da) Imidazoquinoxalinoner,deres azaanaloger og fremgangsmåde til fremstilling deraf
IT1216716B (it) Procedimento per produrre roux.
NO903757L (no) Kitin.kitosan-oligomer med 2,5-anhydromannitol endegruppeeller 2,5-anhydromannose endegruppe og fremgangsmaate til fremstilling derav.
IT1212111B (it) Procedimento per preparare fluoroelastomeri insaturi.
FI883160A7 (fi) Vakuumfoerpackning, isynnerhet foer (malet) rostat kaffe.
DK284988D0 (da) Fremgangsmaade til fremstilling af den 2,2-paracyclophandimer, der anvendes til fremstilling af paylen
NO882054L (no) Sementblanding, saerlig til bruk i borehull.
NO883582D0 (no) Katodisk elektrodeponerbart belegningspreparat.
DE3675590D1 (de) Verfahren zum herstellen von siliziumnitridpulvern.
NO864455D0 (no) Heksahydro-(1)-benzo-(pyrano og tiopyrano)(3,2-c)-pyridiner.
FI902803A7 (fi) DNA-sekvenssi, joka koodaa a-amylaasi-pullulanaasientsyymiä
DK52885D0 (da) 1,3,2-dioxaborinan-forbindelser og fremgangsmaade til fremstilling heraf
DE3789032D1 (de) Mechanismus zur Einstellung eines Ausgangsgliedes.
FI882465A0 (fi) Benzofuro (3,2-c) kinolinfoereningar.
FI906009A7 (fi) Menetelmä des(64,65)-proinsuliinin valmistamiseksi
NO812115L (no) Fortilsetning, og fremgangsmaate for fremstilling derav.
FI883265A7 (fi) Menetelmä -fluoriketonien valmistamiseksi.
FI872527A7 (fi) Menetelmä uusien peptidien valmistamiseksi.